Search and Discover China Trade Knowledge from Trusted Sources™
Current Language: English
Popular Search Results
Contact / Blog
Email / RSS
Search this Author
Chinese usher in the Russian m...
"Chinese medicine is amazing, we like Chinese medicine." When asked about the Russian people for every knowledge of Chinese medicine, most people will say. Chinese medicine in Russia has very high...
Emerging markets: performance ...
Reflected the strength of emerging markets in drug sales and production positions Introduction: The numbers do not lie. Pharmaceutical companies in the pharmaceutical and emerging markets, the ...
Billions of dollars of drug sa...
Although a few "blockbuster" drugs faced with a difficult class market environment and the fate of the patent expires, but the global drug market in 2010 reached 850 billion U.S. dollars, or. Centr...
2010, generic drug companies w...
The global pharmaceutical market in 2010 achieved sales of 850 billion U.S. dollars, of which biotechnology drugs and generic drugs hit a new high, reaching 140 billion U.S. dollars and 1,200 billio...
Antibody drug generic internat...
Although the current policy is not clear, and there may be a lot of money invested in production, but drug makers are still hoping to include a variety of monoclonal antibodies, including biosimilar...
EU Member States to be open dr...
Estonia is the European Union, the Baltic Sea region, bordering with Russia, population 1.34 million, is the fastest growing economies in Eastern Europe in recent years, one of the countries, pharma...
EU exit shock Yasukuni medicin...
The face of "Chinese European exit" message and the sharp drop in sales of herbal medicines market situation, "Millennium drugs are" Hebeianguo is through the "transformation of standard processing"...
More and more Westerners, espe...
Highly developed in science and technology in Sweden, hospital favorable conditions, advanced equipment, and the universal enjoyment of public health. However, an increasing number of Swedes look a...
Johnson is expected to high-pr...
According to people close to Saturday, said the acquisition of Johnson & Johnson is currently the Swiss medical device maker Synthes preliminary negotiations, price may be about 200 billion U.S. dol...
The value of new drugs approve...
"BioSocieties" magazine recently published a study that concerns the importance of quality new drug development, more than a simple concern about the number of new drugs approved Currently, you wa...
The United Nations reported th...
April 21 Food and Agriculture Organization said the high incidence of avian influenza H5N1 poultry industry to eradicate highly pathogenic avian influenza virus at least 10 years. The FAO report s...
Found that aging cells at micr...
Hiroshima University, Professor of Cell and Molecular Biology, Tahara Rongjun Xuan cloth, and their research team found that a presence in the cells and the blood, known as "micro-RNA (miR22)" the...
Novartis Gilenya multiple scle...
Novartis is its multiple sclerosis (MS) received oral medication Gilenya celebrate the European passport. Specifically, the European Commission has approved Gilenya (fingolimod, fingolimod) as ...
The second wave of the Europea...
European new drug plan (IMI) to promote the second wave of 8 projects for funding, amounting to 170 million euros investment, involving immune-mediated diseases, cancer, infectious diseases and el...
Israel's development of "elect...
Israeli researchers are developing an electronic nose to detect breathing hope to identify whether the risk of cancer, particularly difficult to diagnose head and neck cancer. Experts say that, re...
Designated brands and trademarks are property of their respective owners. Use of this website constitutes acceptance of SourceJuice.com
Copyright © 2007 - 2009 SourceJuice.com & SourceJuice All Rights Reserved.